US 12,258,339 B2
Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
John W. Babich, New York, NY (US); Justin Wilson, Ithaca, NY (US); Nikki Thiele, Brooktondale, NY (US); James Kelly, New York, NY (US); and Shashikanth Ponnala, Ithaca, NY (US)
Assigned to Cornell University, Ithaca, NY (US)
Filed by Cornell University, Ithaca, NY (US)
Filed on Feb. 23, 2022, as Appl. No. 17/678,782.
Application 17/678,782 is a division of application No. 16/689,856, filed on Nov. 20, 2019, granted, now 11,279,698.
Claims priority of provisional application 62/769,989, filed on Nov. 20, 2018.
Claims priority of provisional application 62/788,700, filed on Jan. 4, 2019.
Claims priority of provisional application 62/792,835, filed on Jan. 15, 2019.
Prior Publication US 2022/0185803 A1, Jun. 16, 2022
Int. Cl. C07D 413/14 (2006.01); A61K 51/04 (2006.01); A61K 51/10 (2006.01); A61K 45/06 (2006.01); C07B 59/00 (2006.01)
CPC C07D 413/14 (2013.01) [A61K 51/0463 (2013.01); A61K 51/0482 (2013.01); A61K 51/1072 (2013.01); A61K 45/06 (2013.01); C07B 59/002 (2013.01)] 1 Claim
 
1. A compound of formula

OG Complex Work Unit Chemistry
or pharmaceutically acceptable salt thereof.